Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Arrowhead Research Corporation (ARWR)

« Back to company index

ARWR Chatter Timeline

Stock Ticker for ARWR

Most Active Tweeters for ARWR

UserTweets
@battagliame30 39
@BikeRieder 19
@truthtracer 17
@engrcat 12
@pt117cool 8

Recent Tweets for ARWR

truthtracer @truthtracer
No bold numerical predictions, but it’s a matter of time before the Locarnini $ARWR trumpeting really gains tractio… https://t.co/CTwYn8wazP
March 21st 2019, 7:03pm
truthtracer @truthtracer
@Dwyanosaurus I see what you see, couple of weeks now. But there really is substance here. $ARWR
March 21st 2019, 6:03pm
SauveRod @SauveRod
@semodough Let RNAi have a chance at it, $ARWR and $ALNY come to mind..
March 21st 2019, 4:03pm
newswithvalue @newswithvalue
$ARWR: Is Arrowhead Pharmaceuticals, Inc.’s (NASDAQ:ARWR) CEO Salary …: https://t.co/3H0l0GhzJs
March 21st 2019, 2:03pm
GaryR_1951 @GaryR_1951
RT @BioBoyScout: $ARWR new US Patent Application published for "5'-Cyclo-Phosphonate Modified Nucleotides." Improved stability and potency…
March 21st 2019, 2:03pm
1111DLH61 @1111DLH61
Would like to see $ARWR break out of the top of the wedge but may take a bit more squeezing
March 21st 2019, 12:03pm
HatchingGains @HatchingGains
$ARWR Pulling back into rising moving averages and attempting to print a higher low. https://t.co/dm8DbRtStT
March 21st 2019, 10:03am
FlyOnTheWallHQ @FlyOnTheWallHQ
RT @FlyOnTheWallHQ: A Little Yeast Works Through The Whole Batch Of Dough_ ARROWHEAD PHARMACEUTICALS $ARWR CEO Confirmation Coming Of New J…
March 21st 2019, 8:03am
BioBoyScout @BioBoyScout
$ARWR new US Patent Application published for "5'-Cyclo-Phosphonate Modified Nucleotides." Improved stability and p… https://t.co/qderTOQeBu
March 21st 2019, 7:03am
UlmHi @UlmHi
Neurotrope Inc. $ARWR Comparing side by side https://t.co/VeCjq1vJJO
March 20th 2019, 11:03pm
MarkC53916729 @MarkC53916729
@RNAiAnalyst @CaesarBiotech Dr Given $ARWR spoke at Jefferies about the possibility that hitting #HBV weekly w/JNJ… https://t.co/xEWmS0uXNs
March 20th 2019, 8:03pm
thefinreviewer @thefinreviewer
Agenus Inc. $ARWR Comparing side by side https://t.co/gPYikxBBcU
March 20th 2019, 8:03pm
FlyOnTheWallHQ @FlyOnTheWallHQ
A Little Yeast Works Through The Whole Batch Of Dough_ ARROWHEAD PHARMACEUTICALS $ARWR CEO Confirmation Coming Of N… https://t.co/EwyVjOWbVc
March 20th 2019, 7:03pm
battagliame30 @battagliame30
RT @truthtracer: @battagliame30 ~To thine own self, be true. $ARWR made a “pivotal” leap. Reverberations of the ARO-AAT pivotal Phase 2-3 w…
March 20th 2019, 7:03pm
battagliame30 @battagliame30
@BikeRieder That’s because, “breakthroughs can happen,” especially at Arrowhead. $ARWR #AROAAT
March 20th 2019, 5:03pm
BikeRieder @BikeRieder
$ARWR It will not take 30 days to get approval from FDA for an in details discussed and prearranged AROAAT Phase II… https://t.co/XvoWZ4Mr5H
March 20th 2019, 5:03pm
_JessieJames100 @_JessieJames100
RT @hedgiehedgerton: $SBPH short interest going out like the tide. (I remember when $ARWR short interest looked like this. It was in the Sp…
March 20th 2019, 4:03pm
hedgiehedgerton @hedgiehedgerton
$SBPH short interest going out like the tide. (I remember when $ARWR short interest looked like this. It was in the… https://t.co/LSJpbLHq07
March 20th 2019, 3:03pm
MarkC53916729 @MarkC53916729
@engrcat Only possible China tariff impact to $ARWR is after JNJ3989 FDA approved and very likely after ARO-AAT is… https://t.co/3OlaHzhLvo
March 20th 2019, 1:03pm
OlympiaReport @OlympiaReport
Analysts Set Arrowhead Pharmaceuticals Inc $ARWR PT at $21.36 https://t.co/DC45x1uOAj
March 20th 2019, 1:03pm
dispatchtribune @dispatchtribune
Arrowhead Pharmaceuticals Inc $ARWR Receives $21.36 Average Target Price from Brokerages https://t.co/ccUNSrOVIw
March 20th 2019, 1:03pm
BikeRieder @BikeRieder
$ARWR In the past, there were some doubts on biotwitter and YMB about FDA not really “friendly” with RNAi companies… https://t.co/LUbyIcPvKS
March 20th 2019, 10:03am
StockTweetsHQ @StockTweetsHQ
RT @StockTweetsHQ: A Little Yeast Works Through The Whole Batch Of Dough_ ARROWHEAD PHARMACEUTICALS $ARWR CEO Confirmation Coming Of New Jo…
March 20th 2019, 9:03am
UnknownPatriot7 @UnknownPatriot7
RT @BikeRieder: $ARWR FDA has changed a lot with S. Gottlieb in charge. This pivotal phase II/III AROAAT trial is based on data from health…
March 19th 2019, 10:03pm
BlogYomi @BlogYomi
Neon Therapeutics Inc. $ARWR https://t.co/dDiv6aBTAR
March 19th 2019, 10:03pm
StockTweetsHQ @StockTweetsHQ
A Little Yeast Works Through The Whole Batch Of Dough_ ARROWHEAD PHARMACEUTICALS $ARWR CEO Confirmation Coming Of N… https://t.co/9U3sWoCEDu
March 19th 2019, 8:03pm
battagliame30 @battagliame30
@cranium88 @MarkC53916729 Not too sure what their (OppyFds) current percentage position of $ARWR is.
March 19th 2019, 5:03pm
MarkC53916729 @MarkC53916729
@engrcat I think most non traders realize that $ARWR has no intention to sell at this point, mgmt has stated repeat… https://t.co/UG7ZpVWbvI
March 19th 2019, 12:03pm
engrcat @engrcat
My theory on $ARWR selling off on good PR’s is that a significant base of holders only see it as a takeout target,… https://t.co/Br6y1FNcVs
March 19th 2019, 11:03am
battagliame30 @battagliame30
@truthtracer I’ve stated before more than once, $ARWR has some of the best PIs (Principal Investigators) from around the world.
March 19th 2019, 4:03am
truthtracer @truthtracer
@battagliame30 ~To thine own self, be true. $ARWR made a “pivotal” leap. Reverberations of the ARO-AAT pivotal Phas… https://t.co/giIdIZNSxI
March 19th 2019, 3:03am
battagliame30 @battagliame30
@truthtracer “If allowed,” in the context of being modest, not dubious. I’m so bullish on $ARWR now, you know that.… https://t.co/jkurtBWB1y
March 19th 2019, 1:03am
battagliame30 @battagliame30
@truthtracer I mean AROAAT and even AROHBV. $ARWR
March 19th 2019, 1:03am
BlogYomi @BlogYomi
Comparing of Hoth Therapeutics Inc. $ARWR https://t.co/jNbEIcnIdP
March 19th 2019, 12:03am
BikeRieder @BikeRieder
$ARWR Dear FDA, based on the new AROAAT trial design: lets do all future RNAi trials My @ArrowheadPharma Way… https://t.co/yO4B1WYyt5
March 18th 2019, 11:03pm
BikeRieder @BikeRieder
$ARWR FDA has changed a lot with S. Gottlieb in charge. This pivotal phase II/III AROAAT trial is based on data fro… https://t.co/kgQFf4GdeM
March 18th 2019, 11:03pm
VM1409 @VM1409
RT @RNA_Biotech: $ARWR IND for -- PIVOTAL -- Phase 2/3 Study of ARO-AAT https://t.co/QKPbzMODrF
March 18th 2019, 10:03pm
battagliame30 @battagliame30
@truthtracer I got it! Great point, and thanks for the clarity, all things good on $ARWR
March 18th 2019, 10:03pm
battagliame30 @battagliame30
@truthtracer “If allowed,” comments referring to future $ARWR programs following a similar AROAAT model. We’re on t… https://t.co/Oo0HA4CfQ9
March 18th 2019, 10:03pm
cranium88 @cranium88
Maybe Baker bros is $ions buyer now that they’ve sold out of $arwr ?
March 18th 2019, 9:03pm
battagliame30 @battagliame30
@truthtracer I strongly AGREE! $ARWR
March 18th 2019, 8:03pm
thefinreviewer @thefinreviewer
aTyr Pharma Inc. $ARWR Comparing side by side https://t.co/4Z9ZVVtI4D
March 18th 2019, 7:03pm
Mcdivot06 @Mcdivot06
@truthtracer @battagliame30 If $ARWR didn’t learn from their ARC filing problem, then there’s a learning disability… https://t.co/YjOaWp16LQ
March 18th 2019, 7:03pm
OlympiaReport @OlympiaReport
$44.63 Million in Sales Expected for Arrowhead Pharmaceuticals Inc $ARWR This Quarter https://t.co/CwrqZM4QbY
March 18th 2019, 6:03pm
WeekHerald @WeekHerald
Arrowhead Pharmaceuticals Inc $ARWR Expected to Post Quarterly Sales of $44.63 Million https://t.co/sIZ7KQ6owJ
March 18th 2019, 6:03pm
truthtracer @truthtracer
@battagliame30 Referencing the “if allowed” mention. Opinion here is $ARWR doesn’t file the IND until there’s a pre… https://t.co/x4rgdfpPki
March 18th 2019, 6:03pm
battagliame30 @battagliame30
@truthtracer $ARWR Phase 2/3 adaptive design process, my reference.
March 18th 2019, 6:03pm
truthtracer @truthtracer
@battagliame30 $ARWR has already laid the foundation of intelligently designed parallel trials neatly at the feet o… https://t.co/17LP9FRDMm
March 18th 2019, 5:03pm
truthtracer @truthtracer
@mhrob Agreed. $ARWR building something special here. Matter of time before diverse media forms turn their attentio… https://t.co/5Y04xMv9FG
March 18th 2019, 5:03pm
battagliame30 @battagliame30
@truthtracer AROAAT-PIVOTAL Phase 2/3 study creates a foundation for other $ARWR programs to follow suit, if allowe… https://t.co/SA8tPtyLss
March 18th 2019, 5:03pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.